GE HealthCare Technologies/$GEHC
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About GE HealthCare Technologies
GE HealthCare Technologies is a leading medical technology firm with leading market share in imaging and ultrasound equipment. The company reports four major segments: imaging (45% of revenue), advanced visualization solutions (26%), patient care solutions (15%), and pharmaceutical diagnostics (14%). The company's sales are geographically diverse, with the United States, EMEA, China, and the rest of the world accounting for 46%, 26%, 11%, and 17% respectively. We estimate approximately half of its revenue is recurring, which consists of servicing (about one third of revenue), pharmaceutical diagnostics (about 10%-15%), and digital solutions (just over 5%).
Ticker
$GEHC
Sector
Primary listing
Employees
54,000
Headquarters
Website
GEHC Metrics
BasicAdvanced
$34B
16.32
$4.55
1.23
$0.14
0.19%
Price and volume
Market cap
$34B
Beta
1.23
52-week high
$89.77
52-week low
$57.65
Average daily volume
3.4M
Dividend rate
$0.14
Financial strength
Current ratio
1.373
Quick ratio
1.015
Long term debt to equity
92.66
Total debt to equity
98.717
Dividend payout ratio (TTM)
3.07%
Profitability
EBITDA (TTM)
3,642
Gross margin (TTM)
39.99%
Net profit margin (TTM)
10.10%
Operating margin (TTM)
14.86%
Effective tax rate (TTM)
22.18%
Revenue per employee (TTM)
$380,000
Management effectiveness
Return on assets (TTM)
5.47%
Return on equity (TTM)
22.38%
Valuation
Price to earnings (TTM)
16.323
Price to revenue (TTM)
1.642
Price to book
3.26
Price to tangible book (TTM)
-7.98
Price to free cash flow (TTM)
22.503
Free cash flow yield (TTM)
4.44%
Free cash flow per share (TTM)
3.3
Dividend yield (TTM)
0.19%
Forward dividend yield
0.19%
Growth
Revenue change (TTM)
4.84%
Earnings per share change (TTM)
4.84%
3-year revenue growth (CAGR)
3.99%
3-year earnings per share growth (CAGR)
2.54%
What the Analysts think about GEHC
Analyst ratings (Buy, Hold, Sell) for GE HealthCare Technologies stock.
GEHC Financial Performance
Revenues and expenses
GEHC Earnings Performance
Company profitability
GEHC News
AllArticlesVideos
GE HealthCare announces U.S. FDA 510(k) clearance for View, a next‑generation diagnostic viewer enabling anywhere‑access to radiologists
Business Wire·4 hours ago
What's Going On With GE HealthCare Technologies Stock?
Benzinga·2 weeks ago
GE HealthCare announces cash dividend for first quarter of 2026
Business Wire·4 weeks ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
FAQs
What’s the current market cap for GE HealthCare Technologies stock?
GE HealthCare Technologies (GEHC) has a market cap of $34B as of March 09, 2026.
What is the P/E ratio for GE HealthCare Technologies stock?
The price to earnings (P/E) ratio for GE HealthCare Technologies (GEHC) stock is 16.32 as of March 09, 2026.
Does GE HealthCare Technologies stock pay dividends?
Yes, the GE HealthCare Technologies (GEHC) stock pays dividends to shareholders. As of March 09, 2026, the dividend rate is $0.14 and the yield is 0.19%. GE HealthCare Technologies has a payout ratio of 3.07% on a trailing twelve-month basis.
When is the next GE HealthCare Technologies dividend payment date?
The next GE HealthCare Technologies (GEHC) dividend payment is scheduled for May 15, 2026.
What is the beta indicator for GE HealthCare Technologies?
GE HealthCare Technologies (GEHC) has a beta rating of 1.23. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.